![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/50 | (2006.01) |
A61K 9/5026 | (2013.01) | ||
C12N 9/86 | (2006.01) | ||
A61K 9/5078 | (2013.01) | ||
A61P 1/00 | (2006.01) | ||
A61K 38/50 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/546 | (2013.01) | ||
A61K 9/50 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 31/546 | (2006.01) | ||
C12Y 305/02006 | (2013.01) | ||
A61P 1/00 | (2018.01) | ||
Y02A 50/30 | (2018.01) |
(11) | Number of the document | 3265119 |
(13) | Kind of document | T |
(96) | European patent application number | 16762286.9 |
Date of filing the European patent application | 2016-03-07 | |
(97) | Date of publication of the European application | 2018-01-10 |
(45) | Date of publication and mention of the grant of the patent | 2023-10-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/021152 |
Date | 2016-03-07 |
(87) | Number | WO 2016/144856 |
Date | 2016-09-15 |
(30) | Number | Date | Country code |
201562129199 P | 2015-03-06 | US | |
201562167006 P | 2015-05-27 | US | |
201562260979 P | 2015-11-30 | US |
(72) |
SLIMAN, Joseph , US
|
(73) |
Theriva Biologics, Inc. ,
9605 Medical Center Drive
Suite 270, Rockville, MD 20850,
US
|
(54) | SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION |
SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION |